Brief: Pacific Biosciences Of California Inc Reports Q3 Adjusted Loss Per Share Of $0.32
Nov 7 (Reuters) - Pacific Biosciences of California Inc
PACB.O :
* PACBIO ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS
* PACIFIC BIOSCIENCES OF CALIFORNIA INC Q3 REVENUE FELL 7
PERCENT
TO $32.3 MILLION
* PACIFIC BIOSCIENCES OF CALIFORNIA INC - QTRLY LOSS PER
SHARE
$0.34
* PACIFIC BIOSCIENCES OF CALIFORNIA INC - QTRLY ADJUSTED
LOSS PER
SHARE $0.32
Source text for Eikon: ID:nPnbrMzcta
Further company coverage: PACB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacific Biosciences of California
See all newsBrief: Pacbio And Verily Health Announce Multi-Year Strategic Collaboration
Pacific Biosciences of California, Inc. reports results for the quarter ended June 30 - Earnings Summary
Pacific Biosciences Q2 adj. loss bigger than estimates on margin pressure
Brief: Pacific Biosciences of California Q2 EPS USD -0.14
Pacific Biosciences of California Inc expected to post a loss of 13 cents a share - Earnings Preview